1. Home
  2. EGF vs CODX Comparison

EGF vs CODX Comparison

Compare EGF & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EGF
  • CODX
  • Stock Information
  • Founded
  • EGF 2006
  • CODX 2013
  • Country
  • EGF United States
  • CODX United States
  • Employees
  • EGF N/A
  • CODX N/A
  • Industry
  • EGF Trusts Except Educational Religious and Charitable
  • CODX Medical/Dental Instruments
  • Sector
  • EGF Finance
  • CODX Health Care
  • Exchange
  • EGF Nasdaq
  • CODX Nasdaq
  • Market Cap
  • EGF 35.1M
  • CODX 33.2M
  • IPO Year
  • EGF N/A
  • CODX 2017
  • Fundamental
  • Price
  • EGF $9.69
  • CODX $1.28
  • Analyst Decision
  • EGF
  • CODX Hold
  • Analyst Count
  • EGF 0
  • CODX 1
  • Target Price
  • EGF N/A
  • CODX $2.00
  • AVG Volume (30 Days)
  • EGF 9.7K
  • CODX 122.7K
  • Earning Date
  • EGF 01-01-0001
  • CODX 08-08-2024
  • Dividend Yield
  • EGF 5.17%
  • CODX N/A
  • EPS Growth
  • EGF N/A
  • CODX N/A
  • EPS
  • EGF N/A
  • CODX N/A
  • Revenue
  • EGF N/A
  • CODX $6,677,935.00
  • Revenue This Year
  • EGF N/A
  • CODX N/A
  • Revenue Next Year
  • EGF N/A
  • CODX N/A
  • P/E Ratio
  • EGF N/A
  • CODX N/A
  • Revenue Growth
  • EGF N/A
  • CODX N/A
  • 52 Week Low
  • EGF $9.02
  • CODX $0.98
  • 52 Week High
  • EGF $10.47
  • CODX $1.89
  • Technical
  • Relative Strength Index (RSI)
  • EGF 61.19
  • CODX 49.43
  • Support Level
  • EGF $9.26
  • CODX $1.22
  • Resistance Level
  • EGF $9.86
  • CODX $1.39
  • Average True Range (ATR)
  • EGF 0.08
  • CODX 0.10
  • MACD
  • EGF 0.03
  • CODX -0.01
  • Stochastic Oscillator
  • EGF 65.00
  • CODX 47.42

About EGF Blackrock Enhanced Government Fund Inc.

Blackrock Enhanced Government Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide shareholders with current income and gains. The fund seeks to pursue the objectives by investing in a portfolio of U.S. Government and U.S. Agency securities and utilizing an option overwriting in an effort to enhance the fund's distribution rate and total return performance.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: